Archer staff and affiliates working in semiconductor chip foundry facilities. Source: Archer Materials
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Archer Materials (AXE) develops sensing pathways to detect genetic information through its biochip technology
  • The company’s technology is being developed to detect diseases through analysis of biological specimen droplets using graphene-based sensor devices
  • The reactions developed have the potential for on-chip detection and quantification of specific DNA or RNA fragments relevant to viruses and bacteria
  • Archer’s CEO Dr Mohammad Choucair says this provides the biochemical foundations to potentially allow for future operations and applications of the biochip
  • Shares have been trading 7.3 per cent higher at $1.32

Archer Materials (AXE) has developed sensing pathways to detect genetic information through its biochip technology.

The company is developing its biochip which aims to detect diseases through analysis of biological specimen droplets using graphene-based sensor devices integrated in on-chip devices.

Last month, Archer announced it had fabricated, on silicon wafers, nano-sized biochip components inside hair-thin microfluidic channels required for the processing, mixing and transportation of biological specimens.

Now, it has developed its first biochemical reactions for the detection and quantification of nucleic acid sequences, both DNA and RNA, for potential use and application at room temperature in its biochip technology.

According to the company’s CEO, Dr Mohammad Choucair, this development provides the biochemical foundations to potentially allow for future operations and applications of Archer’s biochip in the detection of various diseases.

“There are few examples of lab-on-a-chip technologies that detect nucleic acids without the need for PCR,” he said.

“Archer’s biochemical processes could potentially allow for on-chip detection of pathogens, with several practical advantages, including eliminating cold-logistics supply chain requirements and the need for PCR, if favourable.”

Shares were trading 7.35 per cent higher at $1.32 at 2:06 pm AEDT.

AXE by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX holds green gains and signs off in the sunshine

The ASX200 closed .6 of a per cent up with every sector finishing in the green…
The Market Online Video

Infini Resources gearing up for UAV geophys survey over Portland Creek

Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland…

Week 18 Wrap: Fed prompts joy and pain; modern monetary theory gains traction & Brent takes a breather

The big stories that mattered in Week 18 of 2024 – plus a selection of headlines…